Free Trial
Investment Research Tools for the A.I. EraStart My Trial

NovaBay Pharmaceuticals (NBY) SEC Filings & 10K Form

NovaBay Pharmaceuticals logo
$1.32 +0.12 (+10.00%)
As of 01:19 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Recent NovaBay Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
10/03/2025
4:12 PM		NovaBay Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/23/2025
3:30 PM		NovaBay Pharmaceuticals (Filer)
Form DEF 14A
09/18/2025
3:33 PM		NovaBay Pharmaceuticals (Filer)
Form DEFA14A
09/18/2025
3:33 PM		NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2025
3:05 PM		NovaBay Pharmaceuticals (Filer)
Form PRE 14A
09/04/2025
6:21 PM		NovaBay Pharmaceuticals (Subject)
POPLAR POINT CAPITAL MANAGEMENT LLC (Filed by)
Form SCHEDULE 13D/A
08/26/2025
3:18 PM		Lazar David E. (Reporting)
NovaBay Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/26/2025
3:06 PM		NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/26/2025
3:11 PM		Lazar David E. (Filed by)
NovaBay Pharmaceuticals (Subject)
Form SCHEDULE 13D
08/19/2025
4:29 PM		NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2025
3:36 PM		NovaBay Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/04/2025
11:46 AM		NovaBay Pharmaceuticals (Subject)
POPLAR POINT CAPITAL MANAGEMENT LLC (Filed by)
Form SCHEDULE 13D
04/15/2025
11:40 AM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:46 AM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:50 AM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:11 AM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:18 AM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:22 AM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
11:30 AM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
3:30 PM		FAKHRY JAD (Reporting)
NovaBay Pharmaceuticals (Issuer)
POPLAR POINT CAPITAL GP LLC (Reporting)
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting)
POPLAR POINT CAPITAL PARTNERS LP (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/19/2025
3:33 PM		NovaBay Pharmaceuticals (Filer)
Form DEF 14A
03/11/2025
3:35 PM		NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2025
6:07 AM		NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2025
6:08 AM		NovaBay Pharmaceuticals (Filer)
Form DEFA14A
02/06/2025
5:30 PM		NovaBay Pharmaceuticals (Subject)
POPLAR POINT CAPITAL MANAGEMENT LLC (Filed by)
Form SCHEDULE 13G/A
02/04/2025
3:58 PM		NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2025
3:58 PM		NovaBay Pharmaceuticals (Filer)
Form DEFA14A
01/23/2025
7:12 AM		NovaBay Pharmaceuticals (Filer)
Form DEFA14A
01/23/2025
7:13 AM		NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2025
3:27 PM		NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
5:06 PM		NovaBay Pharmaceuticals (Subject)
POPLAR POINT CAPITAL MANAGEMENT LLC (Filed by)
Form SCHEDULE 13G
01/10/2025
6:03 AM		NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2024
6:00 AM		NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2024
3:12 PM		NovaBay Pharmaceuticals (Filer)
Form DEFA14A
12/09/2024
6:05 AM		NovaBay Pharmaceuticals (Filer)
Form DEFA14A
11/26/2024
3:08 PM		NovaBay Pharmaceuticals (Filer)
Form DEFA14A
11/22/2024
3:27 PM		NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
7:10 AM		NovaBay Pharmaceuticals (Filer)
Form DEFA14A
11/13/2024
4:15 PM		NovaBay Pharmaceuticals (Filer)
Form DEFA14A
11/12/2024
3:52 PM		NovaBay Pharmaceuticals (Filer)
Form DEFA14A
11/08/2024
4:31 PM		Hudson Bay Capital Management LP (Filed by)
NovaBay Pharmaceuticals (Subject)
Form SC 13G/A
11/06/2024
3:46 PM		NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
7:15 AM		NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
7:19 AM		NovaBay Pharmaceuticals (Filer)
Form DEFA14A
10/16/2024
3:27 PM		NovaBay Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
3:19 PM		NovaBay Pharmaceuticals (Filer)
Form DEFM14A
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NYSEAMERICAN:NBY) was last updated on 10/9/2025 by MarketBeat.com Staff
From Our Partners
Bitcoin grabs headlines, but smart money likes this token
Bitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...
Crypto 101 Media | Sponsoredtc pixel
Building The Infrastructure for the Coming Financial Reset
While China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...
Intellistake | Sponsoredtc pixel
Magnificent 7 being replaced by the “Hidden 7”?
BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...
Chaikin Analytics | Sponsoredtc pixel
Capital Gains Tax Strategies for Seniors
Capital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...
SmartAsset | Sponsoredtc pixel
Your Bank Account Is No Longer Safe
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...
Priority Gold | Sponsoredtc pixel
REVEALED: Something Big Happening Behind White House Doors
What I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...
Paradigm Press | Sponsoredtc pixel
An $8 trillion-dollar discovery 17,000 ft underwater
A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...
Porter & Company | Sponsoredtc pixel
A Huge Shift Is Underway in America
Wall Street legend issues chilling new warning: "I've never seen anything as dangerous as this" The man who...
Stansberry Research | Sponsoredtc pixel